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ABSTRACT 
 
Neurokinin Receptor Expression in the Lymphatic System. (April 2009) 
 
Parth Vijay Khade 
Department of Biomedical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Dave C. Zawieja 
Department of Systems Biology and Translational Medicine 
 
 
 
The lymphatic system plays important roles in the maintenance of body fluid 
homeostasis, lipid absorption and immune function. These functions are accomplished 
by its contractile activities that result in the flow of lymph. One of the important 
modulators of lymphatic function and lymph flow is Substance P (SP), a neuropeptide of 
the tachykinin family that is associated with sensory innervation of lymphoid tissue. It 
mediates its functions through G protein coupled receptors NK1R and NK3R. However, 
it is unclear which specific receptors are involved in SP action in the lymphatic system. 
This project specifically focused on the expression pattern of the two neurokinin 
receptors in different rat lymphatic tissues and lymphatic cell lines measured by western 
blots. The mean ratio of NK1R/GAPDH was found to be 1.766 ± 0.120 in rat mesenteric 
lymphatic muscle cell lines and 1.443 ± 0.264 in rat thoracic duct muscle cell lines. The 
mean ratio of NK3R/GAPDH was found to be 0.371 ± 0.051 in rat mesenteric lymphatic 
muscle cell lines and 0.733 ± 0.063 in rat thoracic duct muscle cell lines. This molecular 
information will be useful in our future studies to determine the specific mechanisms of 
SP on lymphatics and to help elucidate the role of SP in the modulation of lymphatic 
function.  
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NOMENCLATURE 
 
SP Substance P 
NK1R Neurokinin 1 Receptor 
NK3R Neurokinin 3 Receptor 
RTDMC Rat Thoracic Duct Muscle Cell 
RMLMC Rat Mesenteric Lymphatic Muscle Cell 
GAPDH   Glyceraldehyde 3-Phosphate Dehydrogenase 
GPCR G-Protein Coupled Receptor 
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CHAPTER I 
INTRODUCTION 
 
The lymphatic system 
 
The lymphatic system is a specialized part of the cardiovascular system that is intimately 
involved in the maintenance of body fluid balance, protein homeostasis and immune 
function. It is one of the primary systems that returns fluids and proteins from interstitial 
tissue to blood in the circulatory system. The lymphatic system is comprised of the 
conducting system, which includes lymph capillaries, vessels, and right thoracic ducts, 
as well as lymphoid tissue, which is comprised of lymphocytes and various white blood 
cells contained in connective tissue through which lymph passes. This tissue includes the 
thymus, bone marrow, and lymph nodes. The conducting system is responsible for the 
transportation of lymph through lymphatic channels, while lymphoid tissue is 
responsible for immune functions in response to infections and the spreading of tumors. 
Lymph is formed when interstitial fluid enters the lymph capillaries. Lymph components 
interact with blood components via their respective sinuses within the lymph nodes. The 
lymphatic system has no central pump, but uses spontaneous contraction of lymphatic 
vessels, to lead to lymph flow. The contraction of lymph vessels is influenced by neural, 
physical, and humoral factors. These factors act on the lymphatic system to regulate 
lymph flow under pathological and physiological conditions. A dysfunctional lymphatic 
circulation can result in a wide range of clinical disorders including edema, altered 
lymphocyte circulation, depressed immune function and impaired lipid metabolism (1). 
It is known that lymphatic function is critical to the development and resolution of 
edema; however there are only few efficacious therapies, as well as a nearly complete 
lack of medicinal treatment options for lymphatic dysfunction. 
_______________ 
This thesis follows the style of The American Journal of Pathology. 
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 This is mainly due to the poor understanding of contractile activity of lymphatic muscle 
cells that is essential for lymph flow (2,3). Thus investigation of the mechanisms 
generating or regulating lymphatic muscle contractile function is important to better 
understand lymphatic function and obtain deeper insights into the pathogenesis and the 
effective treatment of lymphedema (4).  
 
 
Previous functional studies have shown that Substance P stimulates contraction of rat 
mesenteric lymphatic vessels. Since lymph flow is an important factor during 
inflammation and immune function, it is important to study the effects that SP might 
have on it. SP is found and released from C-sensory nerve fibers which surround 
lymphatic vessels in the body. SP secreted during inflammation by lymphatic vessels 
could be responsible for lymphocyte and immune activation. At low concentrations, SP 
also enhances lymphatic contractility and pump efficiency. In quiescent vessels, this 
stimulation of lymphatic contraction frequency causes an active pumping state, resulting 
in an increased lymph flow (5). SP is also able to modify lymphatic pump function by 
reducing the resting lymphatic diameter (EDD), thus causing an increase in smooth 
muscle cell tone. It is proposed that SP release is graded and is thus able to modify 
lymphatic vessel function and hence lymph flow in a concentration dependent manner 
(6). The increased contraction of vessels is important because increased lymph flow can 
be vital to minimize the formation of edema.  
 
 
Substance P 
 
Substance P is a mammalian 11-amino acid neuropeptide that belongs to a family of 
structurally related peptides called tachykinins, which include neurokinin A and 
neurokinin B. SP, NKA, and NKB all have a particular carboxyl-terminal motif in 
common (Phe-X-Gly-Leu-MET-NH2) and are derived from preprotachykinins through 
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proteolytic processing (7). SP is the major mediator of inflammatory responses and 
affects multiple aspects of immune cell function, and is often associated with cells of the 
lymphoid tissue. Some of the biological responses of Substance P include motor control, 
contraction of smooth muscle, vasodilation and sensory perception. Substance P can act 
both directly and indirectly to elicit its effects on target tissue. For example, SP can 
directly stimulate endothelium-dependent nitric oxide production to increase 
vasodilation, or it can stimulate the release of cytokines and chemokines, which 
indirectly leads to vasodilation and increased permeability (6). SP is known to mediate 
its effects through neurokinin receptors (NK1R, NK2R, NK3R). These receptors are 
seven transmembrane G-protein coupled receptors that all bind SP albeit with varying 
affinities, with NK1R having the highest affinity for SP. NK1R and NK2R are localized 
to smooth muscle cells and to a few inflammatory cells. NK1R expression is also found 
in the muscular wall of submucosal blood vessels, enteric neurons and, in surface 
epithelial cells. NK3R is found throughout the brain (8).  
 
 
Although SP displays the strongest affinity for the NK1R, NK2R emerges as the prime 
receptor for SP mediated signaling in esophageal smooth muscle (8). It is not clearly 
understood which specific neurokinin receptor plays a key role in lymphoid tissue, but it 
is suggested that SP maybe acting through a combination of these receptors in the 
lymphatic system (6). However there is no documented evidence on the expression of 
these receptors in the lymphatic tissue.  
 
 
Signaling pathways of Substance P 
 
There are many signaling pathways in the body which Substance P acts through to 
induce its effects. Studying these pathways is integral in determining treatments for 
related physiological conditions. One of the primary signaling pathway through which 
  4 
Substance P acts on that has been studied is the MAP Kinase (MAPK) Pathway. This 
pathway is present in many different systems, for example – SP stimulates the 
expression of TNF-α mRNA in peritoneal mast cells through the P38 and JNK MAPK 
pathway (9). Substance P also acts in human astrocytomas and glioblastomas by 
stimulating NK1R to activate the MAPK pathway through the activation of PKC (10).  
 
 
Substance P has also been shown to stimulate the synthesis of chemokines in pancreatic 
acinar cells by acting through the NF-kB pathway (11). NF-kB is a protein transcription 
factor that binds to DNA located within the intronic enhancer in B-cells and plasma 
cells. Chemokines are cytokines which illicit chemotaxis in surrounding cells, and are 
considered pro-inflammatory. These inflammatory mediators also play a role in 
pathogenesis. Substance P acts through the NK1 receptor to activate the NF-kB 
transcription factor and greatly increase the synthesis of CC chemokine MCP-1, CC 
chemokine MIP-1α, and CXC chemokine MIP-2. One chemokine in particular, MCP-1, 
has been shown to be released by acinar cells to mediate inflammation in acute 
pancreatitis. This is significant because a systemic inflammation response can result, 
which can lead to the dysfunction of multiple organs and even death (9). 
 
 
Other mechanisms through which Substance P acts include the inositol phosphate and 
calcium signaling pathways. Substance P has been shown to produce excitatory and 
inhibitory effects in the neurons of the nucleus tractus solitarii in the central nervous 
system. Most of the time Substance P produces an excitatory effect however, through the 
mobilization of intracellular calcium, however Substance P has been shown to depress 
transmission of sensory input to bronchopulmonary neurons by acting at presynaptic 
NK1 receptors to decrease glutamate release (glutamate is the principal excitatory 
neurotransmitter at this). This is done by activating a calcium dependent potassium 
current which hyperpolarizes vagal afferent neurons. Overall, Substance P controls the 
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reflex regulation of respiratory function and depresses the frequency of eEPSCs 
(excitatory postsynaptic currents). Abnormalities in the regulation of respiratory function 
can lead to conditions such as bronchitis, asthma, and chronic obstructive pulmonary 
disease (12).  
 
 
It has been shown that all three receptor subtypes (NK1R, NK2R, and NK3R) are 
present in the smooth muscle of the human airway. Although Substance P (which causes 
changes in airway contraction) mostly acts on NK1R, NK2R and NK3R have binding 
affinity for tachykinins neuropeptides similar to Substance P – Neurokinin A and 
Neurokinin B, respectively. All three of these receptors are able to induce the release of 
intracellular calcium from the sarcoplasmic reticulum of the human airway smooth 
muscle by coupling to Gq protein mediated inositol 1,4,5-triphosphate, also known as the 
IP3 receptor. IP3 mediates the initial elevation of calcium concentration. This, along 
with the sustained release phase of calcium, initiates contraction in the smooth muscle 
surrounding the airway. The changes in airway resistance are important when 
considering pharmacological treatments for respiratory diseases, including obstructive 
lung diseases (13). 
 
 
Tachykinin signaling in esophageal smooth muscle has also been characterized. The 
primary neurokinin receptors (NK1R, NK2R, and NK3R) have been found to be located 
on esophageal smooth muscle cells. Tachykinins including SP primarily mediate their 
effects through the NK2 receptor in these cells.  These effects include Ca2+ influx 
through L-type channels, Ca2+ release from intracellular stores, and activation of the INSC 
current. Thus, the presence of tachykinin signaling in the enteric nerves of the GI tract 
will cause circular and longitudinal contraction, which plays an integral role in 
mediating peristalsis (8). 
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CHAPTER II 
METHODS 
 
Tissue isolation 
 
Frozen lymphatic thoracic, mesenteric, cervical and iliac tissues were available in the 
Sponsor’s laboratory. 
 
 
Cell culture 
 
Rat thoracic duct lymphatic muscle cells (RTDMC) and rat mesenteric lymphatic muscle 
cells (RMLMC) isolated from rat thoracic and mesenteric tissue explants respectively 
were available in the laboratory. Cells were cultured in DMEM supplemented with 10% 
FBS and 1% antibiotics. The cells were maintained in a 37oC incubator with 10% CO2. 
Maintenance of the cell cultures included washing, feeding, trypsinizing, splitting, and 
freezing of the cells. All activity involving cell cultures was conducted inside a hood to 
prevent contamination. RTDMC and RMLMC cells were initially plated and cultured on 
35 mm dishes, grown to confluence, trypsinized, and then transferred subsequently to 60 
100 mm dishes.  
 
 
Washing cells 
 
The cell cultures were washed daily to remove any debris/waste that had accumulated, 
so that the cells would be able to grow unhindered in a healthy environment. Old media 
was discarded, and cells were washed with DPBS (Dulbecco’s Phosphate Buffered 
Saline). 
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Feeding cells 
 
The cell cultures were fed with fresh media to obtain the appropriate nutrients for 
growth. The media used was DMEM (Dulbecco’s Modified Eagle Medium) 
supplemented with 10% FBS (Fetal Bovine Serum) and 1% triple antibiotics (to prevent 
bacterial growth). This complete media included different peptidases and enzymes 
necessary for cell culture growth that were not present in plain media (glucose only). 
After feeding, cell cultures were placed back inside a 37 oC incubator.  
 
 
Trypsinizing cells 
 
Cells were trypsinized once they became confluent. The cells were then split - part or all 
of the cell culture in one plate was transferred to another plate. Adding trypsin to the cell 
cultures allowed the cells to cleave from their substrate (the dish) and move freely. Cell 
cultures were trypsinized after being washed with DPBS. Once the buffer was removed 
from the dish, .25% EDTA-Trypsin was added. 800 uL was used for 35 mm plates, 
while 1 mL was used for 100 mm plates. The plates were rotated from side to side to 
ensure proper distribution of trpysin. Immediately after trypsin was added to the 
cultures, they were placed inside of the 37 oC incubator for 3 – 5 minutes as that is the 
optimal temperature for trypsin action. The cultures were then taken out and observed 
underneath a light microscope to ensure that the cells were no longer adhered to the 
plate. Next, approximately 4 mL of DMEM were added. The serum in the media was 
used to stop the action of trypsin.  
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Splitting cells 
 
This step took place after DMEM had been added and thoroughly mixed with the 
trypsinized cell mixture. About half of the mixture was pipetted out and added to a new 
100 mm plate. 
 
 
Freezing cells 
 
Some of the cell cultures were frozen back for later use. Freezing media was composed 
of 50% DMEM, 40% FBS, and 10% DMSO. First, old media was removed from the 
culture plates and the plate was then washed with 1 mL of DPBS. Cells were then 
trypsinized. After cells were completely trypsinized, 2 mL of DMEM were added to stop 
the effects of trypsin. Next, 3 more mL of plain media (glucose) were added. Cells were 
thoroughly mixed by pipetting up and down to ensure a homogenous suspension. The 
cells suspension was then transferred into 15 mL tubes. Each tube had 6 mL of media. 
Then, the tubes were centrifuged at 1000 rpm for 10 minutes. A pellet of the cells was 
formed at the bottom of each tube. The supernatant was discarded. Depending on the 
size of the pellet, 500 uL of freezing media was then added/tube to be frozen and the cell 
pellet was resuspended. This was then transferred into cryovials and stored -80 o C for 2-
3 days and then subsequently transferred to liquid nitrogen. 
 
 
Protein isolation 
 
Protein was isolated from the different rat lymphatic tissues (thoracic, cervical, and 
mesenteric lymphatic duct) and RTDMC and RMLMCs. Cells were grown to confluence 
on 100 mm plates and then scraped using protein lysis buffer. Protein lysis buffer 
contained protease inhibitors to prevent protein degradation and ETDA-trypsin to cleave 
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cells from substrate. Cells and tissues were sonicated in an SDS protein lysis buffer. The 
samples were sonicated for 3 minutes and then placed on ice for 1 minute. This process 
was repeated 3 times. The samples were then boiled for 5 minutes. Protein samples were 
stored at -80 o C until future use. 
 
 
Western blot 
 
Western blotting is a useful technique for the identification and quantification of specific 
proteins in complex mixtures of proteins. The protein isolated from rat tissues and cell 
lines were separated on a 4-20% gradient SDS-polyacrylamide gel. Bio-Rad Precast 
Tris-HCL gels were used to separate proteins. The 12-well gel was 8.6 cm x 6.8 cm and 
comprised of 4% stacking gel (4-20% resolving gel). The gel was run in a Tris-Glycine 
buffer (10x). This was then transferred to a nitrocellulose membrane overnight. Protein 
transfer was verified by Ponceau S staining. The membrane was then soaked in TBS 
(Tris buffered saline) buffer to wash off Ponceau stain. The membrane was then blocked 
with 5% milk solution in TBS. The primary antibodies (NK1R, NK3R) were then added 
to the membrane at the appropriate dilution and incubated overnight at 40C. The 
membranes were then washed with TBS 3 times for 10 minutes each and the 
corresponding secondary antibody was added. Antibody binding was detected by an 
electrochemiluminescence method using the Pierce Detection system using an X-ray 
film. The blot was then stripped off and re-probed with another primary antibody as 
before. Protein expression analysis for each of the two receptors was done in five 
replicates. The blots were stripped off using immunopure IgG elution buffer and probed 
with a housekeeping gene GAPDH to check for equal loading. Results were expressed as 
mean±SEM. 
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CHAPTER III 
RESULTS 
 
Rat thoracic duct muscle cells and rat mesenteric lymphatic muscle cells were cultured 
and reached confluency in 5 - 7 days. To determine the concentration of NK1R and 
NK3R, RTDMC and RMLMC lysates which contained these protein receptors were 
isolated. Cell lysate was obtained through the use of protein lysis buffer from both 
RTDMC and RMLMC cultures. Protein lysate was obtained from 5 different RTDMC 
and RMLMC cultures, so that 5 different replicates could be tested. The purpose of 
using 5 different replicates from each cell line was to obtain more accurate statistical 
data when calculating average ratios.  
 
 
SDS page 
 
A western blot probing for alpha smooth muscle actin was first run to determine the 
optimal concentration of protein lysate to be loaded into the stacking gel for separation. 
Actin was used due to its prevalence in smooth muscle cells. It is a globular protein and 
has a molecular weight of 42 KDa. 5 wells were loaded with samples of Actin which 
increased in concentration by 5 μL. 5 μL, 10 μL, 15 μL, 20 μL, and 30 μL were loaded 
into consecutive wells of a SDS-polyacrylamide gel. The gel was run and transferred to a 
blot, which was verified through Ponceau S stain. A western blot was then run, which 
probed alpha smooth muscle actin with an actin primary antibody at a concentration of 
1:10,000. A Mouse IgG secondary antibody of concentration 1:10,000 was then used to 
probe the actin primary antibody. The optimal concentration was determined to be 20 μL 
– it was at this concentration that clear, sharp bands of actin protein were shown. Thus, 
20 μL of RTDMC and RMLMC protein lysate would be inserted into each well for the 
SDS-PAGE.  
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Since a 12 well stacking gel was used, all 5 replicates from each cell line were able to be 
loaded in alternating fashion into a single gel. The first well of the gel was loaded with a 
protein marker, the next 10 wells were loaded with alternating samples of RTDMC and 
RMLMC protein lysate replicates, and the last well was left empty. SDS-PAGE was run 
to separate all protein from the RTDMC and RMLMC lysate into separate bands. The 
progress of protein separation was tracked using glycerol dye. The SDS-PAGE ran to 
completion, that is, all protein was separated, in 45 minutes. The gel was transferred to a 
membrane overnight, and the resulting blot was stained with Ponceau S stain to verify 
protein transfer. The blot is shown below in figure 1. 
 
 
 
Figure 1.  Ponceau S Stain of first RTDMC and RMLMC protein blot 
 
 
The first well of this blot was loaded with 20 μL of marker protein. The blue-colored 
bands from the marker protein were used to indicate the molecular weights precisely so 
as to determine which bands corresponded to NK1R and NK3R proteins. The molecular 
weight for NK1R is 53 KDa and the molecular weight for NK3R is 66 KDa. The table 
 1       2      3      4      5      6      7      8     9     10   11   
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for this marker is shown on Table 1, with the proteins numbered from the top down on 
the blot. 
 
 
Table 1. Molecular weights of protein marker 
Band # MW (KDa) 
1 170.8 
2 109.5 
3 78.9 
4 60.4 
5 47.2 
6 35.1 
7 29.9 
8 18.3 
9 13.7 
10 5.7 
 
 
On this blot, the 2nd, 4th, 6th, 8th, and 10th wells were loaded with RTDMC samples. The 
3rd, 5th, 7th, 9th, and 11th wells were loaded with RMLMC samples. Although each well 
was loaded with an equal amount of lysate, lanes 3, 5, and 9 seemed to contain a smaller 
amount of protein. When these lanes are compared to lanes 2, 4, 6, 7, 8, 10, and 11, a 
clear difference is noted in the amount of protein present. This smaller amount of 
RMLMC protein lysate also clearly corresponds to a smaller amount of NK1R and 
NK3R, as is indicated by the protein marker. Because of this, another gel was to run to 
obtain the necessary amount of samples for the proposed 5 replicates. However, all 5 
wells loaded with RTDMC samples (2nd, 4th, 6th, 8th, and 10th wells) showed adequate 
amount of protein in equal concentrations, including NK1R and NK3R. Thus, the protein 
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samples of NK1R and NK3R found in those 5 wells would be able to be used when 
calculating the average ratio to GAPDH.  
 
 
Another SDS-PAGE was run with alternating wells of RTDMC and RMLMC smooth 
muscle cell lysate to compensate for the smaller amount of protein lysate observed in 
wells 3, 5, and 9 in the blot from figure 1. 20 μL of protein lysate were again loaded into 
each well, with RTDMC and RMLMC samples alternating lanes. The gel was 
transferred to a membrane overnight, and the resulting blot was stained with Ponceau S 
stain to verify protein transfer. The new membrane is presented below in figure 2. 
 
 
 
Figure 2.  Ponceau S Stain of second RTDMC and RMLMC protein blot 
 
 
This blot presented a more equal distribution of protein within each well. Also, the 
amount of separated protein now appeared consistent from well to well. This was 
important as each well was loaded with equal amounts of protein lysate, so an equal 
amount and distribution of protein would be expected. 
 
     1      2       3       4      5       6       7       8      9      10     11    
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Western blots 
 
Now that two gels with an equal distribution of protein were obtained and transferred to 
their respective blots, the western blot protocol was started. Both blots were probed with 
primary antibodies for NK1R and NK3R. The concentration values for both primary and 
secondary antibodies for NK1R and NK3R had been previously standardized; these 
same values were used to probe the blots in this experiment.  
 
 
The concentration of NK1R antibody was determined to be 1:1000 – 10 μL of primary 
antibody was put into 10 mL of 5% milk blocking solution. The secondary antibody used 
for NK1R was Rabbit IgG (immunoglobulin G). Its standardized concentration was 
determined to be 1/10,000 – 1 μL of secondary antibody was put into 10 mL of 5% milk 
blocking solution.  
 
 
The concentration of NK3R antibody was determined to be 1:2000 – 5 μL of primary 
antibody was put into 10 mL of 5% milk blocking solution. . The secondary antibody 
used for NK3R was also Rabbit IgG (immunoglobulin G). Its standardized concentration 
was determined to be 1/8,000 – 1.25 μL of secondary antibody was put into 10 mL of 
5% milk blocking solution.  
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The concentration of the GAPDH antibody was determined to be 1:1000 – 10 μL of 
primary antibody was put into 10 mL of 5% milk blocking solution. The secondary 
antibody used for GAPDH was also Rabbit IgG (immunoglobulin G). Its standardized 
concentration was determined to be 1/5,000 – 2 μL of secondary antibody was put into 
10 mL of 5% milk blocking solution.  
 
 
ECL detection 
 
The membranes were probed for NK1R, NK3R, and GAPDH with primary and 
secondary antibodies using the western blot protocol, described previously in the 
methods section. Blots were stripped after each probing with an immunopore IgG elution 
buffer. Antibody binding was detected using the electrochemiluminescence method, and 
x-ray films of the western blots were developed using the Pierce Detection System. The 
results of the ECL detection are presented below in figures 3, 4, and 5. 
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Fig. 3 NK1R western blot using ECL detection method 
 
 
The images in figure 3 display the developed film of both 1st and 2nd blots detecting 
antibody binding to NK1R. Exposure to H2O2 and luminol was varied to give optimal 
density of bands with minimal background. It is interesting to note that in both blots 
NK1R and NK3R expression occurred in doublets. It is also interesting to note that 
antibody binding to a protein of greater molecular weight than 170.8 KDa was detected 
in only in RMLMC lanes of the second blot. Optimal time for exposure of the 1st blot 
1 
2 
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was found to be 5 minutes. Optimal time for exposure of the 2nd blot was found to be 10 
minutes. 
 
 
 
Fig. 4 NK3R western blot using ECL detection method 
 
 
2 
1 
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The images in figure 4 display the developed film of both 1st and 2nd blots detecting 
antibody binding to NK3R. Optimal time for exposure of the 1st blot was found to be 10 
seconds. Optimal time for exposure of the 2nd blot was found to be 30 seconds. Once 
again, NK1R and NK3R expression occurred in doublets. 
 
 
 
Fig. 5 GAPDH western blot using ECL detection method 
2 
1 
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The images in figure 5 display the developed film of both 1st and 2nd blots detecting 
antibody binding to GAPDH. Both blots were probed with the housekeeping gene 
GAPDH to check for equal loading. Optimal time for exposure of the 1st blot was found 
to be 30 seconds. Optimal time for exposure of the 2nd blot was found to be 3 minutes.  
 
 
Ratios of adjusted volume 
 
As the ultimate purpose of this project was to determine the protein expression pattern of 
NK1R and NK3R receptors in different lymphatic muscle cell lines, the relative 
expression ratios of protein receptors to those of control housekeeping gene GAPDH 
were determined using the Bio-Rad software program Quantity 1. Quantity 1 was able to 
analyze a wide variety of biological samples, including chemiluminescent samples. 
Image samples could be magnified, rotated, and resized. Total and average quantities, as 
well as determine relative and actual amounts of protein were able to be measured. 
 
 
In the tables below, each index represents a protein pool sample from a different plate of 
cells. The adjusted volume (INT*mm2) of the receptors NK1R and NK3R from both rat 
thoracic duct muscle cells and rat mesenteric lymphatic muscle cells was measured using 
Quantity 1, along with the respective adjusted volume of GAPDH. The adjusted volumes 
of both receptor proteins and GAPDH were recorded. These values were then used to 
calculate the expression ratio of the protein receptors to those of GAPDH 
(NK1R/GAPDH and NK3R/GAPDH). The mean ratio, standard deviation, and the 
standard error of mean of all ratios were also calculated and recorded. 
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Table 2. Ratios of adjusted volume of NK1R to GAPDH in RTDMC 
RTDMC ‐ NK1R 
Index  Name 
Adj. Vol. 
NK1R 
Adj. Vol. 
GAPDH 
Ratio of 
NK1R to 
GAPDH 
Mean Ratio  Standard 
Deviation  SEM 
1  U1  1801.903  1585.929 1.136182  1.44295041  0.591197766 0.264392
2  U2  1577.919  1613.129 0.978173       
3  U3  1338.951  1345.776 0.994929       
4  U4  1925.942  829.9217 2.320631       
5  U5  1807.722  1012.822 1.784838       
 
 
Table 2 above contains data for the expression of NK1R in RTDMC replicates. The 
index column lists all replicates in the order obtained. 5 replicates were obtained for the 
NK1R protein receptor in the RTDMC line. The adjusted volume of NK1R ranged from 
1339 INT*mm2 – 1926 INT*mm2. The adjusted volume of GAPDH for these replicates 
ranged from 830 INT*mm2 to 1613 INT*mm2. Ratios were calculated by finding the 
quotient values between the adjusted volumes of NK1R and GAPDH. The average ratio 
was calculated to find the best representative ratio of NK1R between all RTDMC 
replicates. The standard deviation and standard error of mean were also calculated to 
check for consistency – the relatively high standard deviation and standard error of mean 
indicate that further tests might be beneficial to obtain more consistent results. 
 
 
Table 3. Ratios of adjusted volume of NK1R to GAPDH in RMLMC 
RMLMC ‐ NK1R 
Index  Name 
Adj. Vol. 
NK1R 
Adj. Vol. 
GAPDH 
Ratio of 
NK1R to 
GAPDH 
Mean Ratio  Standard 
Deviation  SEM 
1  U1  1313.573  797.9397 1.64620594  1.76581797 0.169156954 0.119612
2  U2  1208.126  640.7695 1.885429999      
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Table 3 above contains data for the expression of NK1R in RMLMC replicates. The 
index column lists all replicates in the order obtained. Only 2 replicates were obtained 
for the NK1R protein receptor in the RMLMC line due to insufficient optical density and 
slightly excessive background on the developed x-ray film. The adjusted volume of 
NK1R ranged from 1208 INT*mm2 to 1313 INT*mm2. The adjusted volume of GAPDH 
for these replicates ranged from 641 INT*mm2 to 798 INT*mm2. Ratios were calculated 
by finding the quotient values between the adjusted volumes of NK1R and GAPDH. The 
average ratio was calculated to find the best representative ratio of NK1R between all 
RMLMC replicates. Although only two replicates were present, the standard deviation 
and standard error of mean were still calculated to check for consistency. 
 
 
Table 4. Ratios of adjusted volume of NK3R to GAPDH in RTDMC 
RTDMC – NK3R 
Index  Name 
Adj. Vol. 
NK3R 
Adj. Vol. 
GAPDH 
Ratio of 
NK3R to 
GAPDH 
Mean Ratio  Standard 
Deviation  SEM 
1  U1  813.3941  1340.899 0.606603428 0.73278743 0.188121409 0.062707
2  U2  797.1263  1056.784 0.754294599      
3  U3  614.6596  983.8624 0.624741476      
4  U4  919.2005  850.354  1.08096213       
5  U5  859.6411  927.3261 0.92701055       
6  U6  813.8922  1613.129 0.504542516      
7  U7  719.9644  1345.776 0.534980884      
8  U8  657.293  829.9217 0.791993975      
9  U9  779.8294  1012.822 0.769957303      
 
 
Table 4 above contains data for the expression of NK3R in RTDMC replicates. The 
index column lists all replicates in the order obtained. 9 replicates were obtained for the 
NK3R protein receptor in the RTDMC line. The adjusted volume of NK3R ranged from 
615 INT*mm2 to 919 INT*mm2. The adjusted volume of GAPDH for these replicates 
ranged from 641 INT*mm2 to 798 INT*mm2. The average ratio was calculated to find 
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the best representative ratio of NK3R between all RTDMC replicates. The standard 
deviation and standard error of mean were also calculated to check for consistency. The 
relatively low standard error of mean for NK3R in this cell line indicates consistent 
fairly consistent ratios. 
 
 
Table 5. Ratios of adjusted volume of NK1R to GAPDH in RMLMC 
RMLMC – NK3R 
Index  Name 
Adj. Vol. 
NK1R 
Adj. Vol. 
GAPDH 
Ratio of 
NK3R to 
GAPDH 
Mean Ratio  Standard 
Deviation  SEM 
1  U1  1304.138  2306.054 0.565527829 0.37076312 0.115114754 0.051481
2  U2  1230.915  3337.563 0.368806615      
3  U3  957.5141  3323.107 0.28813823       
4  U4  1101.01  3158.178 0.348621856      
5  U5  807.8421  2857.382 0.282721093      
 
 
Table 5 above contains data for the expression of NK3R in RMLMC replicates. The 
index column lists all replicates in the order obtained. 5 replicates were obtained for the 
NK3R protein receptor in the RMLMC line. The adjusted volume of NK3R ranged from 
808 INT*mm2 to 1304 INT*mm2. The adjusted volume of GAPDH for these replicates 
ranged from 2306 INT*mm2 to 3338 INT*mm2. The average ratio was calculated to find 
the best representative ratio of NK3R between all RMLMC replicates. The standard 
deviation and standard error of mean were also calculated to check for consistency. The 
relatively low standard error of mean for NK3R in this cell line indicates consistent 
ratios. 
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Plotted results 
 
The results from the tables above are expressed as mean ratio ± SEM in figures 6 and 7 
below. Two graphs are presented – the first for NK1R, and the second for NK3R. Both 
RMLMC and RTDMC cell lines are included in the graph for each receptor. The average 
ratios for each cell line are plotted as bars while the standard errors of mean are included 
as error bars for an accurate representation.  
 
 
 
Figure 6.  Mean ratio ± SEM of NK1R 
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Figure 7.  Mean ratio ± SEM of NK3R 
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CHAPTER IV 
SUMMARY AND CONCLUSIONS 
 
In conclusion, NK1R was shown to have slightly greater expression in RMLMC lines 
than in RTDMC lines, and NK3R was shown to have significantly greater expression in 
RTDMC lines than in RMLMC lines. The specific expression ratio of NK1R/GAPDH 
was found to be 1.766 ± 0.120 in RMLMC lines and 1.443 ± 0.264 in RTDMC lines. 
The specific expression ratio of NK3R/GAPDH was found to be 0.371 ± 0.051 in rat 
mesenteric lymphatic muscle cell lines and 0.733 ± 0.063 in rat thoracic duct muscle cell 
lines.  As RMLMC cell lines were isolated from rat mesenteric lymphatic tissue beds, 
and RTDMC lines were isolated from thoracic duct tissue beds, these ratios could also 
indicate the slightly greater presence of NK1R in rat mesenteric lymphatic muscle 
tissues, and significantly greater presence of NK3R in rat thoracic duct muscle tissues. It 
will be important in future studies to investigate the expression of these receptors in 
tissues as well.  
 
 
It was also interesting to note that NK1R and NK3R were found to be expressed in 
doublets. This could occur because both NK1R and NK3R could have similar structural 
and conformational sites of phosphorylation. The NKRs could also be expressed as 
doublets due to N-glycosylation of residue sites which enhances GPCR stability in the 
plasma membrane and possibly protects receptors from proteolytic degradation (14). 
NK1R contains two N-linked glycosylation sites, Asn-14 and Asn-18 (15). This is 
significant as both NK1R and NK3R are G-protein coupled receptors (GPCRs) which 
take part in several different pathways, including the Map Kinase pathway as well as the 
inositol phosphate and calcium signaling pathways. As the primary function of GPCRs is 
to transduce external stimuli into intracellular signals, the greater stability of these 
receptors could play a further role in their signal transduction. N-glycosylated receptors 
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have been shown to display greater functional cell surface expression and more rapid 
internalization upon ligand binding. Finally, it has been suggested that kinase activity 
and self-dimerization depends on protein N-glycosylation (16).  
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